Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HemosIL CL HIT-IgG(PF4-H)

K-Number: K243374 · 2025-01-28

Decision Date2025-01-28
Product CodeLCO
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HemosIL CL HIT-IgG(PF4-H) is a medical device manufactured by Instrumentation Laboratory (IL) Co.. It received FDA 510(k) clearance on 2025-01-28 under approval number K243374. The device is classified under product code LCO. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HemosIL CL HIT-IgG(PF4-H)?

HemosIL CL HIT-IgG(PF4-H) is a medical device that received FDA 510(k) clearance on 2025-01-28. It is manufactured by Instrumentation Laboratory (IL) Co.. The 510(k) number is K243374.

When was HemosIL CL HIT-IgG(PF4-H) approved by the FDA?

HemosIL CL HIT-IgG(PF4-H) received FDA 510(k) clearance on 2025-01-28, under approval number K243374.

What company makes HemosIL CL HIT-IgG(PF4-H)?

HemosIL CL HIT-IgG(PF4-H) is manufactured by Instrumentation Laboratory (IL) Co..

What is the FDA product code for HemosIL CL HIT-IgG(PF4-H)?

The FDA product code for HemosIL CL HIT-IgG(PF4-H) is LCO.

Other Devices by Instrumentation Laboratory (IL) Co.

Related Devices (Code: LCO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.